{"product_id":"nsj-fy12091-100ug","title":"MADD Antibody \/ MAP kinase-activating death domain, 100 ug","description":"\u003cp\u003eMADD antibody detects MAP kinase-activating death domain protein, encoded by the MADD gene. MAP kinase-activating death domain protein is a multi-domain protein involved in apoptosis regulation, MAPK signaling, and vesicle trafficking. MADD antibody provides researchers with a specific reagent for studying TNF receptor signaling, neurodegeneration, and cancer.\u003cbr\u003e\u003cbr\u003eMAP kinase-activating death domain protein interacts with TNF receptor 1 and other death receptors through its death domain, modulating apoptosis and survival. Research using MADD antibody has shown that it can function as an anti-apoptotic factor by inhibiting TNF-induced cell death, while simultaneously promoting MAP kinase signaling pathways that enhance proliferation. This dual role highlights MADD as a regulator of cell fate decisions.\u003cbr\u003e\u003cbr\u003eStudies with MADD antibody have revealed that MADD is widely expressed but is particularly abundant in brain, endocrine tissues, and tumors. It is expressed as multiple isoforms through alternative splicing, including long and short forms that differ in their ability to regulate apoptosis and signaling. These isoforms allow MADD to act as a context-dependent modulator of signaling cascades.\u003cbr\u003e\u003cbr\u003eDysregulation of MAP kinase-activating death domain protein has been associated with cancer and neurodegenerative disease. Research using MADD antibody has shown that overexpression supports tumor growth by suppressing apoptosis, while mutations or altered expression in neurons contribute to neurodegenerative pathology. Elevated expression has also been observed in thyroid cancers and other tumors, positioning MADD as a potential biomarker and therapeutic target.\u003cbr\u003e\u003cbr\u003eBeyond apoptosis, MADD participates in intracellular trafficking. Research using MADD antibody has demonstrated interactions with Rab3 and related GTPases, regulating synaptic vesicle release and exocytosis. This adds a neurobiological dimension to MADD function and explains its abundance in neurons.\u003cbr\u003e\u003cbr\u003eMADD antibody is widely applied in western blotting, immunohistochemistry, and immunoprecipitation. Western blotting quantifies isoform expression across tissues, immunohistochemistry demonstrates tumor expression, and immunoprecipitation identifies receptor and GTPase interactions. These applications make MADD antibody indispensable for apoptosis, signaling, and cancer research.\u003cbr\u003e\u003cbr\u003eBy providing validated MADD antibody reagents, NSJ Bioreagents supports studies into TNF receptor pathways, apoptosis, and disease. Detection of MAP kinase-activating death domain protein provides researchers with insight into how death domain proteins regulate survival and pathology.\u003c\/p\u003e","brand":"NSJ Bioreagents","offers":[{"title":"100 ug","offer_id":51552425050392,"sku":"FY12091","price":449.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0590\/5652\/1400\/files\/get_image_b03ae6fd-d803-4808-8557-565292e1c58d.jpg?v=1768354661","url":"https:\/\/danabiosci.com\/products\/nsj-fy12091-100ug","provider":"Dana Bioscience","version":"1.0","type":"link"}